RU2125869C1 - Способ сухого получения частиц на основе активного начала, сухие частицы, полученные этим способом и их содержащие фармацевтические композиции - Google Patents

Способ сухого получения частиц на основе активного начала, сухие частицы, полученные этим способом и их содержащие фармацевтические композиции Download PDF

Info

Publication number
RU2125869C1
RU2125869C1 RU94016386A RU94016386A RU2125869C1 RU 2125869 C1 RU2125869 C1 RU 2125869C1 RU 94016386 A RU94016386 A RU 94016386A RU 94016386 A RU94016386 A RU 94016386A RU 2125869 C1 RU2125869 C1 RU 2125869C1
Authority
RU
Russia
Prior art keywords
particles
biocompatible polymer
active substance
stirring
mixture
Prior art date
Application number
RU94016386A
Other languages
English (en)
Russian (ru)
Other versions
RU94016386A (ru
Inventor
Жан-Марк Рюиз
Original Assignee
Сосьете Де Консей Де Решерш Э Д' Аппликасьон Сьянтифик
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сосьете Де Консей Де Решерш Э Д' Аппликасьон Сьянтифик filed Critical Сосьете Де Консей Де Решерш Э Д' Аппликасьон Сьянтифик
Publication of RU94016386A publication Critical patent/RU94016386A/ru
Application granted granted Critical
Publication of RU2125869C1 publication Critical patent/RU2125869C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
RU94016386A 1993-05-15 1994-05-13 Способ сухого получения частиц на основе активного начала, сухие частицы, полученные этим способом и их содержащие фармацевтические композиции RU2125869C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939310030A GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same
GB9310030,3 1993-05-15
GB9310030.3 1993-05-15

Publications (2)

Publication Number Publication Date
RU94016386A RU94016386A (ru) 1996-03-27
RU2125869C1 true RU2125869C1 (ru) 1999-02-10

Family

ID=10735537

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94016386A RU2125869C1 (ru) 1993-05-15 1994-05-13 Способ сухого получения частиц на основе активного начала, сухие частицы, полученные этим способом и их содержащие фармацевтические композиции

Country Status (35)

Country Link
JP (1) JP3139913B2 (sv)
KR (1) KR100341261B1 (sv)
CN (1) CN1050534C (sv)
AT (1) AT406017B (sv)
AU (1) AU685094B2 (sv)
BE (1) BE1008323A3 (sv)
BR (1) BR9401968A (sv)
CA (1) CA2123481C (sv)
CH (1) CH688572A5 (sv)
DE (1) DE4416812C2 (sv)
DK (1) DK171454B1 (sv)
DZ (1) DZ1779A1 (sv)
ES (1) ES2097083B1 (sv)
FI (1) FI112915B (sv)
FR (1) FR2705232B1 (sv)
GB (2) GB9310030D0 (sv)
GR (1) GR1002034B (sv)
HK (1) HK1002831A1 (sv)
HU (1) HU220617B1 (sv)
IE (1) IE940392A1 (sv)
IN (1) IN182330B (sv)
IT (1) IT1269508B (sv)
LU (1) LU88482A1 (sv)
MA (1) MA23194A1 (sv)
NL (1) NL9400795A (sv)
NO (1) NO307403B1 (sv)
NZ (1) NZ260520A (sv)
OA (1) OA09939A (sv)
PL (1) PL175780B1 (sv)
PT (1) PT101518B (sv)
RU (1) RU2125869C1 (sv)
SE (1) SE519004C2 (sv)
SG (1) SG46631A1 (sv)
TN (1) TNSN94046A1 (sv)
ZA (1) ZA943316B (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2456066C2 (ru) * 2007-03-19 2012-07-20 Просоникс Лимитед Способ получения кристаллов

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69435055T2 (de) * 1993-01-06 2008-12-04 IPSEN Manufacturing Ireland Ltd., Blanchardstown Bioabbaubare Polyester zur Herstellung ionischer molekularer Konjugate mit bioaktiven Polypeptiden
DK0678018T3 (da) * 1993-01-06 2003-04-28 Kinerton Ltd Ion molekylærkonjugater af bionedbrydelige polyestere og bioaktive polypeptider
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
US5858531A (en) * 1996-10-24 1999-01-12 Bio Syntech Method for preparation of polymer microparticles free of organic solvent traces
US6867181B1 (en) 1997-06-02 2005-03-15 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
ES2491866T3 (es) 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH
KR100558119B1 (ko) 2000-06-16 2006-03-10 가부시키가이샤 닛폰 쇼쿠바이 가교 중합체, 그것의 제조 방법 및 용도

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH672887A5 (sv) * 1987-10-14 1990-01-15 Debiopharm Sa
WO1989003678A1 (en) * 1987-10-30 1989-05-05 Stolle Research & Development Corporation Low residual solvent microspheres and microencapsulation process
DE3916020C2 (de) * 1989-05-17 1994-06-01 Burkhard Dr Wichert Retardierende Mikropartikel aus bioabbaubaren Polyestern; Verfahren zu deren Herstellung unter Verzicht auf toxische Lösungsmittel und diese Mikropartikel enthaltende pharmazentische Zubereitungen
KR0168849B1 (ko) * 1990-04-12 1999-01-15 요시또시 가즈오 피목 조성물 및 그의 제조방법
JP3116311B2 (ja) * 1990-06-13 2000-12-11 エーザイ株式会社 マイクロスフィアの製法
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
CA2055522A1 (en) * 1990-12-12 1992-06-13 Masako Andoh Microspheres for ophthalmic use
SE467815B (sv) * 1991-05-27 1992-09-21 Bengt Hjalmar Aagerup Med Firm Metod foer att framstaella reproducerbara partiklar av definierad storlek
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
JPH07507768A (ja) * 1992-03-12 1995-08-31 アルカーメス　コントロールド　セラピューティクス，インコーポレイテッド Ａｃｔｈ含有マイクロスフェアの制御放出
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
EP0644771B2 (en) * 1992-06-11 2006-12-06 Alkermes Controlled Therapeutics, Inc. Erythropoietin drug delivery system
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
JP2651320B2 (ja) * 1992-07-16 1997-09-10 田辺製薬株式会社 徐放性マイクロスフェア製剤の製造方法
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
GB2273874A (en) * 1992-12-31 1994-07-06 Pertti Olavi Toermaelae Preparation of pharmaceuticals in a polymer matrix

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2456066C2 (ru) * 2007-03-19 2012-07-20 Просоникс Лимитед Способ получения кристаллов

Also Published As

Publication number Publication date
PL175780B1 (pl) 1999-02-26
IT1269508B (it) 1997-04-01
LU88482A1 (fr) 1994-12-01
FR2705232A1 (fr) 1994-11-25
IN182330B (sv) 1999-03-20
CN1104557A (zh) 1995-07-05
AU685094B2 (en) 1998-01-15
GB2277915B (en) 1997-10-29
AT406017B (de) 2000-01-25
HU9401412D0 (en) 1994-08-29
ATA98794A (de) 1999-06-15
GR1002034B (en) 1995-10-31
CA2123481A1 (en) 1994-11-16
JPH072652A (ja) 1995-01-06
IE940392A1 (en) 1994-11-16
PT101518B (pt) 2000-12-29
AU6308494A (en) 1994-11-17
KR100341261B1 (ko) 2002-09-27
HU220617B1 (hu) 2002-03-28
DK171454B1 (da) 1996-11-04
DZ1779A1 (fr) 2002-02-17
HUT67599A (en) 1995-04-28
NO941810D0 (no) 1994-05-13
SG46631A1 (en) 1998-02-20
NO941810L (no) 1994-11-16
NZ260520A (en) 1994-12-22
CA2123481C (en) 2005-01-11
FR2705232B1 (fr) 1995-08-25
SE9401557L (sv) 1994-11-16
DE4416812C2 (de) 2003-02-06
GB9310030D0 (en) 1993-06-30
NL9400795A (nl) 1994-12-01
SE9401557D0 (sv) 1994-05-05
ES2097083B1 (es) 1997-12-01
TNSN94046A1 (fr) 1995-04-25
SE519004C2 (sv) 2002-12-17
CN1050534C (zh) 2000-03-22
ZA943316B (en) 1995-01-16
BR9401968A (pt) 1994-12-13
DK54994A (da) 1994-11-16
ITMI940931A1 (it) 1995-11-11
JP3139913B2 (ja) 2001-03-05
FI942222A (sv) 1994-11-16
OA09939A (fr) 1994-11-15
NO307403B1 (no) 2000-04-03
BE1008323A3 (fr) 1996-04-02
GB2277915A (en) 1994-11-16
MA23194A1 (fr) 1994-12-31
HK1002831A1 (en) 1998-09-18
FI942222A0 (sv) 1994-05-13
PT101518A (pt) 1995-03-01
DE4416812A1 (de) 1994-11-17
FI112915B (sv) 2004-02-13
CH688572A5 (fr) 1997-11-28
ITMI940931A0 (it) 1994-05-11
ES2097083A1 (es) 1997-03-16
GB9409565D0 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
EP1248596B1 (de) Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
JP3822909B2 (ja) 生物分解性生物適合性微粒子を作成するプロセス
AU2001294458B2 (en) Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
JPH0632732A (ja) 徐放性マイクロスフェア製剤の製造方法
JPH05178740A (ja) 徐放性組成物およびその製造方法
RU2125869C1 (ru) Способ сухого получения частиц на основе активного начала, сухие частицы, полученные этим способом и их содержащие фармацевтические композиции
US5569467A (en) Process for the preparation of microballs and microballs thus obtained
CA2435415A1 (en) Microparticles of biodegradable polymer encapsulating a biologically active substance
DE69715191T2 (de) Verfahren zur Herstellung von Mikropartikeln
JPH08225454A (ja) マイクロスフェア製剤
US20040052855A1 (en) Microparticles of biodegradable polymer encapsulating a biologically active substance and sustained release pharmaceutical formulations containing same
AU2002224721A1 (en) Microparticles of biodegradable polymer encapsulating a biologically active substance